e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Altered expression of the Smad signalling pathway: implications for COPD pathogenesis
Zandvoort A., Postma D. S., Jonker M. R., Noordhoek J. A., Vos J. T. W. M., van der Geld Y. M., Timens W.
Source:
Eur Respir J 2006; 28: 533-541
Journal Issue:
September
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Zandvoort A., Postma D. S., Jonker M. R., Noordhoek J. A., Vos J. T. W. M., van der Geld Y. M., Timens W.. Altered expression of the Smad signalling pathway: implications for COPD pathogenesis. Eur Respir J 2006; 28: 533-541
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Cytokines in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 50S-59S
Year: 2001
Transforming Growth factor beta-1 and Smad signaling has the potential to drive EMT-related changes in smokers and COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
RhoA signalling influences cyclin D1 expression and associated fibroblast turnover: implications for idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling
Year: 2006
Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-?B and EGFR pathways
Source: Eur Respir J 2010; 36: 1425-1435
Year: 2010
Hypoxia inducible factor-1? in human emphysema lung tissue
Source: Eur Respir J 2011; 37: 775-783
Year: 2011
Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD)
Source: ERS Lung Science Conference 2017
Year: 2017
Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension
Source: Eur Respir J 2016; 48: 470-483
Year: 2016
The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma
Source: Eur Respir J 2006; 27: 208-229
Year: 2006
Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis
Source: Eur Respir J 2006; 27: 957-963
Year: 2006
Wnt11 inhibits effects of transforming growth factor-beta1 (TGFbeta1) on lung epithelial phenotype
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Role of tumour necrosis factor-α receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema
Source: Eur Respir J 2006; 28: 102-112
Year: 2006
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Source: Eur Respir J 2008; 32: 1068-1081
Year: 2008
The role of integrins in pulmonary fibrosis
Source: Eur Respir Rev 2008; 17: 157-162
Year: 2008
Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Haemophilus influenzae
(NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Expression and functional analysis of the transforming growth factor (TGF)-β superfamily in pulmonary arterial hypertension: role of PAI-1 in disease progression
Source: Eur Respir J 2007; 30: Suppl. 51, 53s
Year: 2007
Transforming growth factor-? gene polymorphisms in different phenotypes of sarcoidosis
Source: Eur Respir J 2011; 37: 169-175
Year: 2011
The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020
Identification and quantification of NF-kB transcription factor in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept